Jeffrey A Sparks

InstitutionBrigham and Women's Hospital and Harvard Medical School
AddressBoston
Massachusetts
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 33 Covid-19 publications, with a maximum of 4 publications in July 2020
    All Publications
    Bar chart showing 74 publications over 9 distinct years, with a maximum of 20 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sparks JA, Wallace ZS, Robinson PC. Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Curr Opin Rheumatol. 2021 09 01; 33(5):412-418. PMID: 34171857.
      Citations:    Fields:    Translation:Humans
    2. Wallace ZS, Sparks JA, Robinson PC, Machado PM, Yazdany J. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis. 2021 Aug 23. PMID: 34426400.
      Citations:    Fields:    
    3. Sparks JA, Wallace ZS, Seet AM, Robinson PC, Machado PM, Yazdany J. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis. 2021 Aug 13. PMID: 34389604.
      Citations:    Fields:    
    4. Putman M, Sattui SE, Sparks JA, Liew JW, Grainger R, Duarte-García A. Reply. Arthritis Rheumatol. 2021 09; 73(9):1767-1768. PMID: 33779057.
      Citations:    Fields:    
    5. Hausmann JS, Kennedy K, Simard JF, Liew JW, Sparks JA, Moni TT, Harrison C, Larché MJ, Levine M, Sattui SE, Semalulu T, Foster G, Surangiwala S, Thabane L, Beesley RP, Durrant KL, Mateus EF, Mingolla S, Nudel M, Palmerlee CA, Richards DP, Liew DFL, Hill CL, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Sirotich E. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. Lancet Rheumatol. 2021 Oct; 3(10):e707-e714. PMID: 34316727.
      Citations: 3     
    6. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, et al. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146. PMID: 34049860.
      Citations: 16     Fields:    Translation:Humans
    7. Hsu TY, D'Silva KM, Patel NJ, Wang J, Mueller AA, Fu X, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Cook C, Choi HK, Zhang Y, Gravallese EM, Wallace ZS, Sparks JA. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study. Lancet Rheumatol. 2021 Sep; 3(9):e638-e647. PMID: 34095857.
      Citations: 4     
    8. Hsu TY, D'Silva KM, Patel NJ, Fu X, Wallace ZS, Sparks JA. Incident systemic rheumatic disease following COVID-19. Lancet Rheumatol. 2021 Jun; 3(6):e402-e404. PMID: 33842894.
      Citations: 2     
    9. D'Silva KM, Serling-Boyd N, Hsu TY, Sparks JA, Wallace ZS. Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by Shanoj et al. Ann Rheum Dis. 2021 Mar 10. PMID: 33692020.
      Citations: 2     Fields:    
    10. Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Hsu TY, D'Silva KM, Serling-Boyd N, Wallwork R, Todd DJ, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Machado PM, Robinson PC, Yazdany J. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol. 2021 03; 73(3):374-380. PMID: 33146001.
      Citations: 12     Fields:    Translation:Humans
    11. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 07; 80(7):930-942. PMID: 33504483.
      Citations: 85     Fields:    Translation:Humans
    12. D'Silva KM, Serling-Boyd N, Hsu TY, Sparks JA, Wallace ZS. SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease. Ann Rheum Dis. 2021 Jan 12. PMID: 33436385.
      Citations: 2     Fields:    
    13. Egeli BH, Sparks JA, Kim AHJ, Liew JW. Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain? Best Pract Res Clin Rheumatol. 2021 03; 35(1):101658. PMID: 33483287.
      Citations:    Fields:    Translation:Humans
    14. Sattui SE, Graef ER, Liew JW, Sparks JA, Kim AHJ. Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'. Expert Rev Clin Immunol. 2021 01; 17(1):105-107. PMID: 33290667.
      Citations:    Fields:    Translation:Humans
    15. Serling-Boyd N, D'Silva KM, Hsu TY, Wallwork R, Fu X, Gravallese EM, Jorge AM, Zhang Y, Choi H, Sparks JA, Wallace ZS. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic. Ann Rheum Dis. 2021 05; 80(5):660-666. PMID: 33257496.
      Citations: 22     Fields:    Translation:Humans
    16. Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2021 01; 73(1):36-47. PMID: 32741139.
      Citations: 19     Fields:    Translation:Humans
    17. Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020 12 03; 383(23):2291-2293. PMID: 33176080.
      Citations: 227     Fields:    Translation:Humans
    18. Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666. PMID: 32620062.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    19. Duarte-García A, Graef ER, Liew JW, Konig MF, Kim AH, Sparks JA. Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al. Ann Rheum Dis. 2020 Aug 07. PMID: 32769149.
      Citations: 1     Fields:    
    20. Ugarte-Gil MF, Konig MF, Korsten P, Berenbaum F, Kim AH, Sparks JA. Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al. Ann Rheum Dis. 2020 Aug 05. PMID: 32759257.
      Citations:    Fields:    
    21. Scheetz MH, Konig MF, Robinson PC, Sparks JA, Kim AHJ. A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic. ACR Open Rheumatol. 2020 Aug; 2(8):491-495. PMID: 32725866.
      Citations: 3     
    22. Kilian A, Chock YP, Huang IJ, Graef ER, Upton LA, Khilnani A, Krupnikova SDS, Almaghlouth I, Cappelli LC, Fernandez-Ruiz R, Frankel BA, Frankovich J, Harrison C, Kumar B, Monga K, Vega JAR, Singh N, Sparks JA, Sullo E, Young KJ, Duarte-Garcia A, Putman M, Johnson S, Grainger R, Wallace ZS, Liew JW, Jayatilleke A. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. Semin Arthritis Rheum. 2020 10; 50(5):1191-1201. PMID: 32931985.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    23. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu TY, Sparks JA, Wallace ZS. Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al. Ann Rheum Dis. 2020 Jul 13. PMID: 32660976.
      Citations:    Fields:    
    24. Liew JW, Graef ER, Sparks JA, Kim AH. Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al. Ann Rheum Dis. 2020 Jul 09. PMID: 32647030.
      Citations:    Fields:    
    25. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al. Ann Rheum Dis. 2020 Jun 25. PMID: 32586919.
      Citations:    Fields:    
    26. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al. Ann Rheum Dis. 2021 05; 80(5):e64. PMID: 32546600.
      Citations:    Fields:    Translation:Humans
    27. Graef ER, Liew JW, Kim AH, Sparks JA. Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al. Ann Rheum Dis. 2020 May 29. PMID: 32471896.
      Citations:    Fields:    
    28. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'. Ann Rheum Dis. 2020 09; 79(9):1156-1162. PMID: 32457048.
      Citations: 66     Fields:    Translation:HumansCellsPHPublic Health
    29. Graef ER, Liew JW, Kim AH, Sparks JA. Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al. Ann Rheum Dis. 2020 May 18. PMID: 32424027.
      Citations: 1     Fields:    
    30. Ingraham NE, Boulware D, Sparks MA, Schacker T, Benson B, Sparks JA, Murray T, Connett J, Chipman JG, Charles A, Tignanelli CJ. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Crit Care. 2020 04 28; 24(1):182. PMID: 32345336.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    31. Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736. PMID: 32295786.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    32. Centor RM, Kim AH, Sparks JA. Web Exclusive. Annals On Call - COVID-19: Is Chloroquine the Answer? Ann Intern Med. 2020 05 05; 172(9):OC1. PMID: 32271869.
      Citations: 2     Fields:    
    33. Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, Graef ER, Korsten P, Sattui SE, Sirotich E, Ugarte-Gil MF, Webb K, Grainger R. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821. PMID: 32227189.
      Citations: 91     Fields:    Translation:HumansCellsPHPublic Health
    Sparks's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (161)
    Explore
    _
    Co-Authors (194)
    Explore
    _
    Similar People (60)
    Explore
    _